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Rationale Patients with obstructive sleep apnea syndrome (OSA) exhibit an 
early vascular remodelling and alterations of acid arachidonic (AA) pathway. 
Thromboxane A2 (TXA2) is a cyclooxygenase (COX)- derived metabolite of 
AA involved in vascular remodelling. 
Objectives (i) To characterize COX- pathway in apolipoprotein E- de¿ cient 
(ApoE- /- ) mice exposed to chronic intermittent hypoxia (CIH) and in OSA 
patients in comparison to controls; (ii) To establish the speci¿ c role of COX 
pathway activation in OSA- associated atherogenesis. 
Methods 40 male ApoE- /- mice, 14- week- old, were submitted to CIH or 
normoxia (N) for 8 weeks. Atherosclerosis lesions were determined in aortic 
roots. Expression of COX- pathway genes were investigated on aortas. 50 
lean OSA patients free of known cardiovascular risk factor matched with 
25 healthy volunteers (HV) for body mass index and age, were included, as 
well as 56 OSA patients with cardiovascular co- morbidities. Urinary excretion 
of 11- dTXB2 was measured by liquid chromatography- tandem mass spec-
trometry. 116 subjects bene¿ ted to carotid ultrasonography to assess intima 
media thickness (IMT). 
Results Exposure of mice to CIH induced an increase of atherosclerotic 
plaque size in aortic roots (p=0.008). This was associated with an increase of 
COX- 1 (p=0.05) and thromboxane synthase (TXBS) (p=0.03) mRNA levels in 
aortas. Atherosclerotic plaque size signi¿ cantly correlated to mRNA levels of 
COX- 1, COX- 2, TXBS and prostacyclin synthase. In patients, urinary excre-
tion of 11- dTXB2 did not differ between OSA patients free of cardiovas-
cular complications and healthy volunteers, but was increased in OSA patients 
with comorbidities compared to OSA patients without (694.0 (425.9- 1235.6) 
versus 616.0 (354.3- 838.2) pg/mg creatinine respectively; p=0.007). Finally, 
urinary 11- dTXB2 was increased by 30% in OSA patients with carotid hyper-
trophy (IMT>0.8mm) compared to OSA patients without carotid hypertrophy 
(783.0 (582.8- 938.0) versus 592.9 (278.9- 782.5) pg/mg creatinine, respecti-
vely; p=0.02). 
Conclusion COX- pathway is activated in ApoE- /- mice exposed to CIH and 
in OSA patients with associated cardiovascular risk factors. This activation 
seems to be involved in the atherosclerotic process. Therefore, inhibition of 
COX- pathway could be of potential interest in prevention of cardiovascular 
morbidity in OSA patients.
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Background: Small coronary vessels supply small myocardial territories. 
The clinical signi¿ cance of small vessel stenoses is therefore questionable. 
Moreover, percutaneous coronary intervention (PCI) of non- functionally signi-
¿ cant lesions does not improve clinical outcome and might even be associated 
with potential procedural or stent related risks. The aim of this study was to 
assess the clinical outcome of Fractional Flow Reserve (FFR) guided PCI in 
the treatment of small coronary vessel lesions as compared with an Angio- 
guided PCI.
Methods and Results: From January 2004 to December 2008, all patients 
(pts) treated with PCI for stable or unstable angina in small native coronary 
vessels (reference vessel diameter and stent size <3mm) were retrospecti-
vely analyzed. Pts were divided into an Angio- guided and an FFR- guided PCI 
group. A total of 717pts were enrolled (495 Angio- guided, 222 FFR- guided). 
Endpoints were: death, non- fatal myocardial infarction (MI), combined death 
or non- fatal MI, target vessel revascularization (TVR), and procedure costs. 
Major adverse cardiac events (MACE) were de¿ ned as death, non- fatal MI 
and TVR. 
Clinical follow- up was obtained in 97.5% (median follow- up: 3.3 [from 
0.01 to 5] years) of the pts. Seventy- eight pts (35%) had a signi¿ cant FFR 
(<0.80) and underwent PCI. Using a propensity score adjusted Cox analysis, 
pts treated with FFR- guided PCI had signi¿ cantly lower combined death or 
non- fatal MI (HR 0.413, 95%CI 0.227- 0.750, p=0.004), non- fatal MI (HR 
0.063, 95%CI 0.009- 0.462, p=0.007), TVR (HR 0.517, 95%CI 0.323- 0.826, 
p=0.006), and MACE (HR 0.458, 95%CI 0.310- 0.679, p<0.001). No dif-
ference was observed in mortality alone (HR 0.684, 95%CI 0.355- 1.316, 
p=0.255). Procedure costs were also reduced in the FFR guided strategy 
(3253±102 Euros vs. 4714±37 Euros, p<0.0001).
Conclusions: FFR- guided PCI of small coronary arteries is safe and results 
in better clinical outcomes when compared to an Angio- guided PCI.
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Objective: Adiponectin is considered to possess antiatherogenic and car-
dioprotective properties. In patients undergoing percutaneous coronary inter-
vention (PCI), the prognostic value of preprocedural total adiponectin is 
unknown. The present study was designed to address this issue.
Methods: From March 2006 to September 2007, pre- procedural total adi-
ponectin levels were measured in 477 consecutive patients who underwent 
PCI in our institution with a median follow- up of 3.7 years. Patients presen-
ting with acute ST- elevation myocardial infarction (STEMI) were excluded. 
The primary endpoint was the composite of death, non- fatal MI or stroke. 
Target lesion revascularization (TLR) was also examined. 
Results: Median adiponectin level was 17g/ml [25- 75th percentile: 
13- 21g/ml]. The primary endpoint occurred in 76 patients (15.9%). TLR 
was undertaken in 25 patients (5.2%). Female gender, high HDL cho-
lesterol and BNP, low triglyceride levels and lack of pre- treatment with 
beta- blockers were independently associated with high adiponectin level. 
In univariate analysis, adiponectin had a significant positive relationship 
(p=0.002) with the primary endpoint. In multivariate analysis, diabetes 
mellitus, lower creatinine clearance, high CRP and high adiponectin levels 
(hazard ratio=1.05 [95% CI: 1.01- 1.09; p=0.006) were associated with the 
primary endpoint. When patients were divided into tertiles according to 
adiponectin levels, patients in the upper tertile (>20.2g/ml) had twice 
more risk of death, MI or stroke as compared to patients in the lowest 
tertile (<15.1g/ml) (Figure). No association was found between adipo-
nectin levels and TLR (p=0.64).
Conclusions: In contrast to studies in the general population, high pre- 
procedural total adiponectin levels may be associated with increased risk of 
mortality, MI or stroke in patients undergoing PCI.
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Objectives: To determine whether low platelet response to the P2Y12 
receptor antagonist clopidogrel as assessed by VAsodilator Stimulated 
Phosphoprotein À ow cytometry test (VASP- FCT) has the same deleterious 
clinical impact in patients undergoing percutaneous coronary intervention 
(PCI) and treated with or wihtout drug eluting stent (DES).
Background: Delayed struts reendothelialization following DES implan-
tation together with impaired platelet responsiveness to clopidogrel are likely 
to promote thrombotic events after PCI. The platelet VASP- FCT assay is spe-
ci¿ c of the P2Y12 ADP receptor- pathway. In this test, platelet activation is 
expressed as Platelet Reactivity Index (PRI).
Methods: Unselected patients treated by PCI were prospectively enrolled 
and follow- up for one year. In each sub- group, patients were classi¿ ed as low- 
responders (LR: PRI61%) and responders (R: PRI<61%) to clopidogrel. The 
61% threshold was previously de¿ ned as the optimal cut- off value to predict 
cardiac death following PCI.
Results: 855 patients (64 yr±12) (DES=392; BMS=463) undergoing urgent 
(n= 648) or planned (n=207) were prospectively enrolled. PRI values were not 
signi¿ cantly different in BMS vs DES- treated patients. At a mean follow- up 
of 282±102 days, cardiac death (BMS- R: 2.1%, BMS- LR 3.7%, DES- R 5.1%, 
DES- LR 8.5%; p=0.030), death and Re- MI (BMS- R 10.5%, BMS- LR 12.6%, 
DES- R 12.7%, DES- LR 20.3%; p=0.059),  possible stent thrombosis (BMS- R: 
0.4%, BMS- LR 1.2%, DES- R 2.7; DES- LR 4.2% p=0.034) rates were higher 
in DES- LR patients. TVR tend to be lower in DES- R patients (BMS- R: 13.7%, 
BMS- LR 12.4%, DES- R 6.8%, DES- LR 9.5%; p=0.063). Conversely, in BMS 
treated patients, LR was not associated with poorer cardiovascular outcome. 
Conclusions: Interaction between impaired platelet responsiveness to clopi-
dogrel and DES implantation is a strong predictor of adverse cardiovascular 
outcome at one year following PCI.
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Predictive value of renal function degradation before coronary artery 
bypass surgery
Pierre- Alain Pages [Orateur], Victor Aboyans, Benedicte Tanguy, Dania 
Mohty, Philippe Lacroix, Marc Laskar, Patrice Virot
CHU Dupuytren, Limoges, France
Objective. Patients with advanced age and comorbidities are increasingly 
referred for cardiac surgery. Chronic kidney disease (CKD) is a marker of 
poorer post- operative prognosis and is included in peri- operative risk scores. 
However, it is not clear whether recent renal failure occurring after coronary 
angiography has similar prognostic value than long- term CKD. The purpose 
of our study was to compare the prognostic value of recent vs. long- standing 
CKD in patients undergoing CABG.
Methods. We prospectively studied 383 patients undergoing CABG in a 
single center. Demographic and clinical data were collected preoperatively. The 
glomerular ¿ ltration rate (GFR) was evaluated before surgery and coronary 
angiography according to the MDRD- equation. We de¿ ned CKD when GFR 
< 60ml/min/1.73m². Patients were categorized into 3 groups (group 1: no CKD 
prior to surgery; group 2: CKD before coronary angiography and surgery; group 
3: no- CKD before coronary angiography, but CKD before surgery). Multivariate 
Cox proportional hazard analysis was performed to determine the independent 
prognostic factors. The primary outcome was long- term total mortality. The 
secondary outcome was composite, combining long- term death, acute coronary 
syndrome, stroke and coronary revascularization.
Results. During a median follow- up of 39±14 months, poorer prognosis 
was observed in groups 2 and 3 vs. group 1 (¿ gure 1). In the multivariate 
analysis adjusting for confounders, we found an increased risk of morta-
lity (hazard ratio (HR) and 95% con¿ dence interval: 3.9 [1.1- 13.5]; p=0.03) 
and secondary outcome (HR: 3.7 [1.1- 12.8]; p=0.04) in group 3 compared 
to group 1, but no signi¿ cant risk was found in group 2 (mortality: HR 1.1 
[0.5- 2.4]; p=0.79).
Conclusions. Recent preoperative renal dysfunction occuring between 
coronary angiography and surgery is an independent predictor of long- term 
mortality. 
KEYWORDS: Coronary artery bypass; Coronary angiography; 
Kidney Disease; Prognosis; Predictive Factors.
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KAPLAN-MEIER CURVES FOR SURVIVAL FREE OF
DEATH-MI-STROKE ACCORDING TO ADIPONECTIN LEVELS
Follow-up (days)
E
ve
n
t-
fr
ee
 o
f 
« 
D
ea
th
-M
I-
S
tr
o
ke
 »
15.1μg/ml<adiponectin<20.2μg/ml
log rank p = 0.004
Adiponectin>20.2μg/ml
Adiponectin<15.1μg/ml
0
0.6
0.8
1.0
500 1000 1500 2000
Follow-up (days)
S
u
rv
iv
al
 w
it
h
o
u
t 
d
ea
th
 o
r 
re
M
I
log rank p=0.47
0.00 100.00 200.00 300.00 400.00
0.0
1.2
1.4
1.6
1.8
1.0
BMS and PRI < 61% (BMS-R)
DES and PRI > 61% (DES-LR)DES and PRI < 61% (DES-R)
BMS and PRI > 61% (BMS-LR)
Death and myocardial infarction at follow- up
6 Archives of Cardiovascular Diseases Supplements (2012) 2, 1-84
© Elsevier Masson SAS. All rights reserved.
0383
Five- Year Clinical Outcome in Elderly Population with Small Vessel 
Disease Treated with Drug- Eluting Versus Bare- Metal Stenting
Etienne Puymirat [Orateur] (1), Fabio Mangiacapra (2), Aaron Peace (2), Micaela 
Conte (2), Yiannis Ntarladimas (2), Jozef Bartunek (2), Marc Vanderheyden (2), 
William Wijns (2), Bernard De Bruyne (2), Emanuele Barbato (2)
(1) Hôpital Européen Georges Pomipdou (HEGP), Cardiologie, Paris, 
France - (2) Cardiovascular Center Aalst, OLV Hospital, Aalst, Belgique
Background: Drug- eluting stents (DES) are more effective than bare- 
metal stents (BMS) in the treatment of small coronary vessel lesion. There 
are limited data on the safety and ef¿ cacy of DES in this indication in elderly 
patients. We aimed to assess the long- term clinical outcome in elderly patients 
of DES vs. BMS in small vessel disease.
Methods: From January 2004 to December 2008, all elderly patients 
(75 years) treated with stenting of native small coronary arteries (de¿ ned 
as reference vessel diameter and implanted stent < 3mm) were prospectively 
enrolled. According to the type of stent implanted, patients were divided into 
BMS and DES group. Procedural and long- term clinical outcomes were com-
pared between both groups. 
Results: A total of 293 patients were enrolled (175 treated with BMS, 
118 with DES). Clinical follow up was obtained in 96.2% (median follow-
 up 3.7±1.4 years). At ¿ ve years, patients treated with DES showed signi-
¿ cantly lower major adverse cardiac events (MACE) (HR 0.42, 95% CI 
0.24- 0.72, log- rank P=0.002) and target vessel revascularization (TVR) (HR 
0.33, 95% CI 0.14- 0.76, log- rank P=0.009). No signi¿ cant differences were 
observed between the two groups as to death, myocardial infarction and stent 
thrombosis.
Conclusion: In this real- world registry of small vessel disease, DES was 
safe and more effective than BMS in reducing MACE and TVR at 5 years in 
elderly patients.
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Potential clinical bene¿ t of ¿ nal kissing inÀ ation after single stenting 
for the treatment of bifurcation coronary lesions
Dhaker Lahidheb [Orateur], Leila Riahi, Thouraya Filali, Nadhem Hajlaoui, 
Houayda Mahfouthi, Abdeddayem Haggui, Rana Dahmeni, Wafa Fehri, 
Habib Haouala
Hôpital Militaire de Tunis, Cardiologie, Tunis, Tunisie
Purpose: The aim of this study was to evaluate clinical bene¿ t in bifurca-
tion lesions treated with provisonnel stenting strategy and ¿ nal kissing inÀ a-
tion as compared with non- ¿ nal kissing inÀ ation.
Methods: From February 2004 to June 2010, 103 patients with all types of 
Medina bifurcation lesions were enrolled in a prospective study. All patients 
underwent implantation of a stent across the bifurcation and provisional SB 
stenting. 45 (43%) patients were assigned to treatment with ¿ nal kissing 
balloon inÀ ation (FKI group), the others were treated with isolated balloon 
after dilation (n=57, non- FKI group).
Results: No signi¿ cant differences were found between the patients from 
the FKI and non- FKI groups in terms of age, risk factors, clinical status, 
or location of the bifurcation lesions. During 24 months fellow up, eight 
patients experienced a Q- wave acute myocardial infarction: four (7.5%) 
from the non FKI group and four (9%) from the non- KB group. Target 
lesion revascularization was required in 13 patients (12%): 7 from the FKI 
group and 6 from the non- FKI group. Late mortality occurred in 1 patient 
from the FKI group and 1 patient from the non- FKI group. De¿ nite stent 
thrombosis occurs in eight cases (7%): 5 from the FKI group and 3 from 
the non- FKI (p=NS). The incidence of major events at 2 year (death, target 
lesion revascularization, or acute myocardial infarction) was similar in both 
groups: 11 (31%) from the FKI group and 16 (28%) from the non- KB group 
(p=NS).
Conclusion:  no differences in the clinical outcome at 2 year of follow-
 up were observed between the patients with bifurcation lesions treated with a 
simple approach and either a simultaneous ¿ nal KB or an isolated SB balloon 
post- dilation.
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Identi¿ cation of coagulase negative staphylococci in human pathology: 
comparison of different identi¿ cation methods
Celine Longin [Orateur] (1), François Thibault (2), Tiphaine Gaillard (3), 
Nicolas- Charles Roche (4), Jean- Louis Koeck (5), Eric Garnotel (1)
(1) HIA Laveran, Biologie clinique, Marseille, France - (2) Institut de 
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Background: coagulase- negative staphylococci (CNS) are part of the 
normal skin À ora, but can also emerge as opportunistic pathogens like in endo-
carditis. Therefore, to de¿ ne the clinical signi¿ cance of these bacteria, it has 
become increasingly important to accurately identify the CNS to species level. 
Several phenotypic and genotypic methods are available. Mass spectrometry 
is a recent technic wich has not yet been compared to traditional methods in 
CNS identi¿ cation.
Method: we prospectively collected 218 CNS on blood cultures. We 
assessed the identi¿ cation performance of three phenotypic tests (API ID 32 
staph, TAXIden Staph, Vitek system), and MALDI- TOF spectrometry, com-
pared to genotypic identi¿ cation, based on the sequence analysis of the rpoB 
gene, which is considered as the identi¿ cation reference method.
Results: Genotypic methods have better typeability and accuracy than phe-
notypic one but tend to be more expensive and time- consuming. This study pro-
vides evidence of the validity and usefulness of MALDI- TOF Mass Spectrometry 
which appears to have a higher discriminatory power than other phenotypic 
methods, and an excellent correlation with genotypic identi¿ cation. Indeed, 
correct species was obtained in 93% and only 13 isolates were misidenti¿ ed.
Conclusion: in this study, we demonstrate that MALDI- TOF Mass 
Spectrometry is a powerful tool for the identi¿ cation of clinically relevant 
species of CNS, and a promising technique that enables construction of ela-
borate databases. It provides a rapid and inexpensive tool for bacterial iden-
ti¿ cation by extending this strategy to other groups of pathogenic bacteria in 
routine clinical microbiology laboratories.
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